Showing results (61-70 of 543) with videos related to
Sort By:
Pageof 55
American Heart Journal|November 1, 1989
The cost:benefit ratio of acute intervention for myocardial infarction: results of a prospective, matched pair analysisA T Chapekis, K Burek, E J TopolClinical Cardiology|May 1, 1996
Antiplatelet and anticoagulant use after myocardial infarctionG T Almony, J Lefkovits, E J TopolHuman Molecular Genetics|August 24, 2012
Cystic fibrosis in an era of genomically guided therapyP M Barrett, A Alagely, E J TopolProgress in Cardiovascular Diseases|November 5, 1997
Stenting for ischemic heart diseaseG Belli, S G Ellis, E J TopolJournal of the American College of Cardiology|June 7, 2000
Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunctionH A Cooper, D V Exner, M J DomanskiJournal of the American College of Cardiology|June 1, 1995
Lessons we have learned from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded ArteriesD R Holmes, R M Califf, E J TopolCatheterization and Cardiovascular Diagnosis|January 1, 1985
Selection of dilatation hardware for PTCA--1985E J Topol, R K Myler, S H StertzerJournal of the American College of Cardiology|May 1, 1991
Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventionsD W Muller, S G Ellis, E J TopolAnnals of Internal Medicine|December 1, 1985
Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic studyE J Topol, W R Bell, M L WeisfeldtSeminars in Interventional Cardiology : SIIC|November 5, 1999
Diabetes mellitus: biological determinants of atherosclerosis and restenosisS P Marso, K H Mak, E J TopolPageof 55